ES426414A1 - Metodo para producir una preparacion de ciclocitidina seca-da por congelacion. - Google Patents

Metodo para producir una preparacion de ciclocitidina seca-da por congelacion.

Info

Publication number
ES426414A1
ES426414A1 ES426414A ES426414A ES426414A1 ES 426414 A1 ES426414 A1 ES 426414A1 ES 426414 A ES426414 A ES 426414A ES 426414 A ES426414 A ES 426414A ES 426414 A1 ES426414 A1 ES 426414A1
Authority
ES
Spain
Prior art keywords
weight
translation
preparation
machine
legally binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES426414A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kohjin Holdings Co Ltd
Kohjin Co
Original Assignee
Kohjin Holdings Co Ltd
Kohjin Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kohjin Holdings Co Ltd, Kohjin Co filed Critical Kohjin Holdings Co Ltd
Publication of ES426414A1 publication Critical patent/ES426414A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ES426414A 1973-05-17 1974-05-17 Metodo para producir una preparacion de ciclocitidina seca-da por congelacion. Expired ES426414A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5414573A JPS5637967B2 (sv) 1973-05-17 1973-05-17

Publications (1)

Publication Number Publication Date
ES426414A1 true ES426414A1 (es) 1976-07-01

Family

ID=12962379

Family Applications (1)

Application Number Title Priority Date Filing Date
ES426414A Expired ES426414A1 (es) 1973-05-17 1974-05-17 Metodo para producir una preparacion de ciclocitidina seca-da por congelacion.

Country Status (4)

Country Link
JP (1) JPS5637967B2 (sv)
DE (1) DE2423811A1 (sv)
ES (1) ES426414A1 (sv)
FR (1) FR2229416A1 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51139613A (en) * 1975-05-24 1976-12-02 Nippon Shinyaku Co Ltd An absorbable non-crystalline sterol glycoside monopalmitate ester and a method for preparing its pharmaceutical
DE2658406C2 (de) * 1975-12-31 1984-04-26 Asahi Kasei Kogyo K.K., Osaka Verfahren zur Herstellung wasserlöslicher Arzneimittelzubereitungen, enthaltend N↑4↑-Acylcytosin-arabinosid
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
ID21635A (id) * 1996-12-20 1999-07-08 Astra Pharma Prod Komposisi farmasi untuk pengeringan beku
KR0181252B1 (ko) * 1996-12-31 1999-03-20 박원훈 에멀젼 방법에 의한 다공성 매트릭스형 서방성 제제의 제조방법
CA2280130C (en) * 1997-02-05 2007-12-18 Kirin Beer Kabushiki Kaisha Lyophilized compositions containing sphingoglycolipid and process for preparing them
US6417167B1 (en) 1997-02-05 2002-07-09 Kirin Beer Kabushiki Kaisha Lyophilized compositions containing shingoglycolipid and process for preparing them
SE9702680D0 (sv) * 1997-07-11 1997-07-11 Astra Pharma Prod New formulation

Also Published As

Publication number Publication date
JPS505523A (sv) 1975-01-21
FR2229416A1 (en) 1974-12-13
JPS5637967B2 (sv) 1981-09-03
DE2423811A1 (de) 1974-12-05

Similar Documents

Publication Publication Date Title
IL56356A (en) Sodium sesquiglyphosate,process for its preparation and its use in agricultural compositions
JPS52154599A (en) Method for imparting water resistance to molded smoking composition
ES433908A1 (es) Procedimiento para preparar composiciones farmaceuticas, solidas, conteniendo bismuto.
NZ192046A (en) Cementitious composition comprising an acid formate of ammonium, sodium or potassium as an accelerator
ES426414A1 (es) Metodo para producir una preparacion de ciclocitidina seca-da por congelacion.
SE8004043L (sv) Tobakskomposition
JPS536413A (en) Preparation of n-containing polysaccharides
JPS553721A (en) Production of powder of colostrum
JPS53113032A (en) Immune depresants
JPS51146432A (en) Process for preparation of benzanilide derivatives having therapeutic action to immunological disease
ES431758A1 (es) Metodo para producir una preparacion de sal de ciclocitidi-na secada por congelacion.
ES454147A1 (es) Procedimiento para preparar un material sazonante particu- lado.
ES394902A1 (es) Perfeccionamientos introducidos en un procedimiento para lapreparacion de una formulacion detergente.
ES406085A1 (es) Un procedimiento para preparar una composicion detergente.
ES374392A1 (es) Procedimiento para preparar formulaciones de colorante.
JPS545097A (en) Preparation of immobilized glucose isomerase
ES382252A1 (es) Un metodo para la preparacion de tripolifosfato de sodio o potasio.
JPS5279090A (en) Preparation of powdered soy sauce
JPS5315344A (en) Preparation of 5-cyclohexadecene-1-one
JPS53104456A (en) Compression system refrigerator
JPS5247913A (en) Method of preparing concentrated and stable inosine solution
JPS5571702A (en) Antitumorous glucan derivative, its preparation, and carcinostatic substance containing it
ES422155A1 (es) Un procedimiento para la preparacion de 2,2'-anhidro-1-be- ta-d-arabinofuranosil 5-fluorocitosina.
JPS52105280A (en) Preparation of nucleicacidase
JPS51125358A (en) Process for preparing 2,i-dimethyl-3- (2,2-dihalovinyl)-cyclopropaneca rboxylic acid derivatives